Boardroom Alpha
10-K primary document
BAX · Annual Report (Form 10-K) · Filed February 12, 2026

Baxter International Inc10-K exhibit

bax-20251231xexx21.htm
Document

EXHIBIT 21
BAXTER INTERNATIONAL INC.

The following is a list of certain wholly-owned subsidiaries of Baxter International Inc. as of December 31, 2025, omitting some subsidiaries which, when considered in the aggregate, would not constitute a significant subsidiary.
Domestic SubsidiaryIncorporation
Baxter Healthcare CorporationDelaware
Baxter Healthcare of Puerto Rico LLCDelaware
Hill-Rom Services, Inc.Indiana
Welch Allyn Inc.New York
Laboratorios Baxter S.A.Delaware
Synovis Micro Companies Alliance, Inc.Minnesota
Foreign SubsidiaryIncorporation
Baxter Healthcare Pty LtdAustralia
Baxter Belgium SPRLBelgium
Baxter Distribution Center Europe SABelgium
Baxter R and D Europe SPRLBelgium
Baxter SABelgium
Baxter Hospitalar Ltda.Brazil
Baxter Corporation (Canada)Canada
Baxter Healthcare (Shanghai) Company Ltd.China
Baxter Productos Medicos, Ltda.Costa Rica
Baxter S.A.S.France
Baxter Deutschland GmbHGermany
Baxter Healthcare Limited (Hong Kong, China)Hong Kong
Baxter Pharmaceuticals India Pvt Ltd.India
Baxter Innovations & Business Solutions Private Limited (India)India
Baxter Shared Services & Competencies LimitedIreland
Baxter Healthcare S.A.- Ireland Finance BranchIreland
Baxter S.p.A.Italy
Baxter Healthcare LimitedNew Zealand
Baxter Polska Sp. z o.o.Poland
Baxter Healthcare SA (Singapore Woodlands Branch)Singapore
Baxter Pharmaceuticals (Asia) Pte Ltd.Singapore
Baxter, S.L.Spain
Baxter AGSwitzerland
Baxter Healthcare SASwitzerland
Baxter Healthcare Limited (Taiwan)Taiwan
Baxter Holding B.V.The Netherlands
Baxter Netherlands Holding B.V.The Netherlands
Baxter Turkey Renal Hizmetler A.STurkey
Baxter Healthcare LimitedUnited Kingdom


Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer